COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.

Volume: 35, Issue: 3, Pages: 317 - 330
Published: Mar 20, 2021
Abstract
Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target immunity and have the potential to increase the risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and alter its clinical course. We assessed these risks in patients with MS (PwMS). The objective of this study was to describe the overall risk of coronavirus disease 2019 (COVID-19) infection, severe disease course, and potential population-level...
Paper Details
Title
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Published Date
Mar 20, 2021
Journal
Volume
35
Issue
3
Pages
317 - 330
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.